Results 231 to 240 of about 3,759,449 (356)

Mapping ActEarly: Using a child health map to evaluate a City Collaboratory programme on early promotion of good health and wellbeing. [PDF]

PLoS One
Gansallo P, Bryant M, Mansukoski L, Padgett L, Sheringham J, Islam S, Garnett P.   +6 more
europepmc   +1 more source

1.W.P. Posterwalk: Health services and systems research [PDF]

European Journal of Public Health, 2015
openaire   +1 more source

Population‐based linkage of health records in Western Australia: development of a health services research linked database

Australian and New Zealand Journal of Public Health, 1999
C. Holman, A. J. Bass, I. Rouse, M. Hobbs   +3 more
semanticscholar   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Gender-sensitive health service framework for women prisoners in Thailand: A qualitative study. [PDF]

Belitung Nurs J
Kumtanat T, Rungreangkulkij S.
europepmc   +1 more source

Mixed Methods in Biomedical and Health Services Research

Circulation. Cardiovascular Quality and Outcomes, 2013
L. Curry, H. Krumholz, A. O’Cathain, V. P. Clark, E. Cherlin, E. Bradley   +5 more
semanticscholar   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Addressing ableism in healthcare: integrating critical disability theory into health services research. [PDF]

Int J Equity Health
Gooderham E, Smith J, Lavergne R, McCracken RK, Hedden L.   +4 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

A role for cities in sustaining Planetary Health. [PDF]

UCL Open Environ
Aktas YD, Gribble MO, Osborn D, Spini L, Berry P, Aletta F.   +5 more
europepmc   +1 more source